EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intestinal Ultrasound in Acute Severe Ulcerative Colitis Treated with Intravenous Cyclosporine: Case Series

Yusuke Miyatani iD, Joëlle St-Pierre iD, Jeremy Klein, David T Rubin iD, Noa Krugliak Cleveland iD

Crohn's & Colitis 360 · 29.04.2026

DOI: 10.1093/crocol/otag037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crohn's & Colitis 360, online erschienen am 29.04.2026. Verfasst von Yusuke Miyatani und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Chicago Medicine Inflammatory Bowel Disease Center, Department of Medicine, Chicago, IL, United States. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal ultrasound (IUS) has been studied to assess therapeutic response in patients with acute severe ulcerative colitis (ASUC). However, there is no data on sonographic changes occurring in ASUC receiving intravenous (IV) cyclosporine. This case series aims to describe the sonographic changes occurring in hospitalized patients with ASUC receiving IV cyclosporine as salvage therapy.

Methods

This is a retrospective observational study in a single tertiary care center from February 2023 to May 2024. Serial sonographic findings of patients with severe UC treated with IV cyclosporine were collected. Sonographic changes associated with clinical outcomes were analyzed. Outcomes included clinical response (Simple Clinical Colitis Activity Index decrease ≤ 3 at day 3 with discharge on oral cyclosporine) and colectomy.

Results

Nine patients received IV cyclosporine with IUS monitoring; 67% failed ≥2 advanced therapies. Four responded to cyclosporine, four underwent colectomy, and one switched to upadacitinib with subsequent response during the same admission. Clinical responders had a median 31.8% (IQR 26.3-51.2%) reduction in bowel wall thickness (BWT) and 1-scale reduction in modified Limberg score, whereas non-responders demonstrated 7.2% (IQR-54.8-9.0%) reduction in BWT and no change in modified Limberg score. The median time to clinical response was 2.5 days (IQR 1.8-2.6). Baseline BWT was similar between responders and non-responders: 5.2 mm (IQR 3.5-6.5) versus 5.2 mm (3.8-6.7).

Conclusions

A median 31.8% BWT reduction was observed by day 3 among responders, highlighting early sonographic changes associated with response to IV cyclosporine therapy in refractory ASUC.

Schlagwörter

Stichwörter der Autor:innen

acute severe ulcerative colitiscyclosporineintestinal ultrasound

Autor:innen und Institutionen

  • University of Chicago Medicine Inflammatory Bowel Disease Center, Department of Medicine, Chicago, IL, United States.

ORCID-Profile: Yusuke Miyatani, Joëlle St-Pierre, David T Rubin, Noa Krugliak Cleveland

Zitieren

APA

Miyatani, Y., St-Pierre, J., Klein, J., Rubin, D. T., & Krugliak Cleveland, N. (2026). Intestinal Ultrasound in Acute Severe Ulcerative Colitis Treated with Intravenous Cyclosporine: Case Series. Crohn's & Colitis 360. https://doi.org/10.1093/crocol/otag037

Vancouver

Miyatani Y, St-Pierre J, Klein J, Rubin DT, Krugliak Cleveland N. Intestinal Ultrasound in Acute Severe Ulcerative Colitis Treated with Intravenous Cyclosporine: Case Series. Crohn's & Colitis 360. 2026. doi:10.1093/crocol/otag037

BibTeX
@article{Miyatani2026,
  author = {Miyatani, Yusuke and St-Pierre, Joëlle and Klein, Jeremy and Rubin, David T and Krugliak Cleveland, Noa},
  title = {Intestinal Ultrasound in Acute Severe Ulcerative Colitis Treated with Intravenous Cyclosporine: Case Series},
  journal = {Crohn's & Colitis 360},
  year = {2026},
  doi = {10.1093/crocol/otag037}
}
Kostenlos starten →